Study Links Declining Hippocampal Connectivity to Worsening Early Psychosis Symptoms

A collaborative team of researchers from the Max Planck Institute of Psychiatry in Munich and the University of Melbourne has identified potential neural biomarkers that may help forecast how symptoms evolve in young people at risk for psychotic disorders. Published in Nature Mental Health, the investigation examined functional MRI and clinical data from 434 individuals, consisting of 356 high-risk participants and 78 healthy controls, utilizing information from the North American Prodrome Longitudinal Study.

The evaluation revealed that a reduction in functional connectivity within the hippocampus over a span of two months was linked to escalating negative symptoms, such as diminished motivation, worsening depression, and declining psychosocial functioning in subsequent months. However, the study found no measurable association between this declining connectivity and cognitive abilities or positive symptoms like hallucinations. Investigators noted that while the statistical signals were robust, the overall effects remain relatively small due to the clinical heterogeneity of psychiatric symptoms, and individual outcome predictions should not rely on this metric alone.

What to know: The findings suggest that targeting hippocampal connectivity could aid in developing interventions—potentially utilizing noninvasive brain stimulation or exercise regimens—to address hard-to-treat negative symptoms in early-stage psychosis. Readers should consult qualified healthcare professionals for medical guidance regarding personal health decisions.